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Cell culture-adapted variants of hepatitis A virus (HAV) in which the first pyrimidine-rich tract (pY1;
nucleotides 99 to 138) of the 5* nontranslated region has been deleted (D96-137 or D96-139) replicate as well
as parental virus in cultured cells (D. R. Shaffer, E. A. Brown, and S. M. Lemon, J. Virol. 68:5568–5578, 1994).
To determine whether viruses with such large deletion mutations are able to replicate and to produce acute
hepatitis in primates, we reconstructed the D96-137 deletion in the genetic background of a virulent virus which
differs from the wild type by only one mutation in the 2B-coding region (HM175/8Y). Full-length synthetic
D96-137/8Y RNA was injected into the livers of two HAV-seronegative marmosets (Saguinus mystax). Both
animals developed serum liver enzyme elevations and inflammatory changes in serial liver biopsies within 3 to
4 weeks of inoculation which were comparable in magnitude to those observed previously following intrahepatic
inoculation of marmosets with HM175/8Y RNA. Sequencing of RNA from virus shed in feces demonstrated the
presence of the D96-137 deletion. These results indicate that the pY1 sequence of HAV is not required for
efficient viral replication in hepatocytes in situ or for production of acute hepatic injury following intrahepatic
RNA transfection in primates.
Hepatitis A virus (HAV) is a positive-strand RNA virus of
the picornavirus family (genus Hepatovirus) which causes acute
hepatitis in certain primate hosts (16). As with other picorna-
viruses, the genomic RNA of HAV contains a lengthy 59 non-
translated region (59NTR) with a complex secondary and ter-
tiary structure (1) and sequence elements which are essential
for cap-independent viral translation (1, 2, 13, 22) and viral
RNA replication (20). Recent work has shown that a 40-nu-
cleotide (nt) pyrimidine-rich sequence near the 59 end of the
59NTR, designated the first pyrimidine-rich tract [pY1; nt 99 to
138, numbered according to the sequence of the wild-type
HM175 strain of HAV (HM175/wt) (3)], is not required for
efficient replication of virus in cultured African green monkey
or fetal rhesus kidney cells (19). The pY1 tract is located
upstream of the HAV internal ribosomal entry site (IRES) (2,
20, 22) and contains a unique repetitive (U)UUCC(C) motif
(Fig. 1). This region of the 59NTR is sensitive to cobra venom
nuclease V1 digestion centered on the cytidines within the
repetitive motifs (19), suggesting that the pY1 domain is folded
into an ordered structure, perhaps by virtue of noncanonical
base pairing or via single-stranded helical stacking. The func-
tion of the pY1 domain remains unclear.
Studies undertaken with a murine picornavirus, mengovirus,
have shown that deletion of a poly(C) tract which is similarly
placed within the 59NTR of that virus results in variants which
are markedly attenuated in the natural host but which replicate
well in cultured cells (5). Since the general features of the pY1
domain are conserved among all human hepatovirus strains
studied to date, we have wondered whether an HAV mutant
lacking the pY1 domain might be similarly attenuated during
infection of otherwise susceptible primates. If this were the
case, such a virus might have potential as a candidate live
attenuated vaccine against hepatitis A.
The HAV mutants with large deletions involving the pY1
domain which we had studied previously (19) were constructed
in the genetic background of a virus which is highly adapted to
growth in cultured cells, HM175/P2.18f (23), and which is likely
to be highly attenuated in primates (8, 21). Thus, to obtain a
pY1 deletion mutant which could be tested for virulence in
primates, the D96-137 deletion was reconstructed in the ge-
netic background of a virulent virus (HM175/8Y). The nucle-
otide sequence of HM175/8Y is identical to that of HM175/wt
except for a single C-to-U mutation at nt 3889 in the 2B-coding
region (7–9, 11). The 3889 mutation substantially enhances the
growth of wild-type virus in cultured cells, without significantly
impairing the ability of the virus to replicate or cause disease in
primates (8).
PCR was used to amplify the HAV sequence between nt 18
and 170 of the genome-length clone, pD96-137 (19). The pos-
itive-strand PCR primer (wt 118; 59-TTCAAGAGGG
GTCTCCGG, nt 18 to 35) contained a BspEI site at nt 25, and
the negative-strand PCR primer (wt 2170; 59-CCCTGAAC
CTGCAGGAATTAATATTT, nt 170 to 145) contained a PstI
site at nt 162. With the exception of the D96-137 deletion, the
sequence of the template cDNA between nt 18 and 170 dif-
fered from the HM175/8Y sequence only with respect to an
A-to-G mutation at nt 152. Therefore, the negative-strand
PCR primer was designed to change the G at nt 152 to A. The
0.15-kb PCR product was gel purified, digested with BspEI and
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PstI, and cloned into the unique BspEI-PstI site of pG3Zf8Y/
0-632. pG3Zf8Y/0-632 is a subclone containing the 0.6-kb
HindIII-BamHI fragment of HM175/8Y cDNA (nt 0 to 632).
The resulting plasmid was digested with BspEI and BamHI,
and the 0.6-kb fragment was gel purified and ligated with the
9.7-kb DNA fragment resulting from BspEI and partial BamHI
digestion of pHM175/8Y (11). The sequence of the resulting
full-length cDNA clone, pD96-137/8Y, is identical to that of
HM175/wt except for the deletion between nt 96 and 137 and
the C-to-U mutation at nt 3889. A similar strategy was used to
construct pD96-137/wt, which contains the deletion between nt
96 and 137 in the background of the fully wild-type HM175
sequence. The identity of cDNA clones was confirmed by re-
striction endonuclease mapping and by double-stranded DNA
sequencing of the PCR-amplified sequence between nt 25 and
162 (Sequenase reagent kit; United States Biochemical Corp.).
To confirm that RNA derived from these mutant clones
remained infectious, 20 ml of an SP6 in vitro RNA transcrip-
tion mix containing 1 mg of plasmid DNA (and visually esti-
mated to contain approximately 5 mg of full-length HAV
RNA) was used to transfect fetal rhesus monkey kidney
(FRhK-4) cells. Parallel transfections were carried out with
pD96-137/8Y, pHM175/8Y, pD96-137/wt, and pHM175/wt
RNAs. Transfection was accomplished by electroporation us-
ing 83 106 cells per 0.4-cm cuvette and a voltage of 1.50 kV/25
mF, applied twice. Following electroporation, cells were imme-
diately diluted into 4 ml of growth medium in a 60-mm-diam-
eter dish. Cells were maintained at either 31 or 378C with
weekly medium changes before harvest of cell lysates in either
0.05 or 0.1% sodium dodecyl sulfate at 4 or 7 weeks as previ-
ously described (4). Serial dilutions of transfected cell lysates
were tested for viral antigen content by a solid-phase radioim-
munoassay, carried out as previously described (17).
As shown in Table 1, viral replication was documented by
the presence of detectable HAV antigen 4 weeks after trans-
fection of either the HM175/8Y or D96-137/8Y RNA, with
further increases in viral antigen by 7 weeks. Previous experi-
ments have shown that cell culture-adapted virus containing
the D96-137 deletion replicates with comparable if not slightly
greater efficiency at 37 than at 318C (19), as does the parental
cell culture-adapted virus. In contrast, pY1 deletion mutants in
which the deletion extended downstream of nt 141 are tem-
perature sensitive as a result of a defect in RNA synthesis (19,
20). The results from the experiment shown in Table 1 are
consistent with these observations, in that the D96-137/8Y
RNA produced virus which was not temperature sensitive, with
more viral antigen following transfection at 37 than at 318C.
Transfection of the D96-137/8Y RNA produced at least as
much, if not more, viral antigen as the HM175/8Y RNA at
both temperatures. These radioimmunoassay results were con-
firmed by radioimmunofocus infectivity assays of lysates of
transfected cells which were carried out in BS-C-1 cells (data
not shown). Thus, the D96-137 deletion does not impair the
replication of the virulent HM175/8Y virus in cultured FRhK-4
or BS-C-1 cells. Cells transfected at either temperature with
the HM175/wt or D96-137/wt RNA were negative for antigen
at both 4 and 7 weeks, confirming the importance of the 3889
mutation (present in HM175/8Y) in facilitating replication in
cultured cells (9, 11).
To assess the replication competence and pathogenicity of
D96-137/8Y virus in primates, two marmosets (Sanguinus mys-
tax) were infected by direct intrahepatic nucleic acid transfec-
tion (10). Scaled-up SP6 RNA transcription reactions were
carried out to produce D96-137/8Y RNA for intrahepatic in-
oculation. Each marmoset (approximately 0.6 kg in size) re-
ceived a total inoculum of 100 ml of transcription mix contain-
ing 10 mg of pD96-137/8Y cDNA as a template, given as three
separate injections involving both lobes of the liver (10). The
marmosets were bled weekly for 2 weeks prior to intrahepatic
nucleic acid transfection and at weekly intervals thereafter for
the next 15 weeks. Fecal samples and percutaneous needle
biopsies of liver were also obtained at weekly intervals.
As shown in Fig. 2, both marmosets developed evidence of
acute hepatitis within 3 to 4 weeks of intrahepatic transfection
of the D96-137/8Y RNA. The severity of disease was similar
to that seen in previous intrahepatic transfections with
HM175/8Y RNA (10). Serum isocitrate dehydrogenase, ala-
nine aminotransferase, and g-glutamyl transpeptidase activi-
ties all became elevated to levels typical of acute hepatitis A in
the marmoset. By 7 weeks posttransfection, the serum enzyme
levels had returned to near normal in both animals.
Hematoxylin-and-eosin-stained sections of percutaneous
FIG. 1. Sequence and proposed secondary structure in the region of the pY1
domain of HM175/8Y virus and the D96-137/8Y pY1 deletion mutant.
TABLE 1. Radioimmunoassay detection of HAV antigen in lysates
of FRhK-4 cells transfected with synthetic viral RNAs
RNA
cpm
4 wk 7 wk
318C 378C 318C 378C
HM175/8Y 483 560 1,146a 2,560a
D96-137/8Y 569 1,313 1,982 5,165a
HM175/wt 46 46 NDb 32
D96-137/wt 40 39 46 47a
None (mock transfection) ND 33 ND 87
aMean value from two replicate transfections.
b ND, not done.
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liver biopsy samples were examined without knowledge of the
identity of samples. Sections were graded from 0 to 41, based
on the degree of necroinflammatory changes. Previous intra-
hepatic transfections of marmosets with HM175/wt or
HM175/8Y RNA have typically resulted in histologic scores of
21, rarely 31, and never 41 (6, 10). As shown in Fig. 2, both
animals transfected with the D96-137/8Y RNA developed
necroinflammatory changes in the liver which were similar in
timing and severity to those observed previously in animals
transfected with HM175/8Y RNA (10).
Viral RNA was detected in the feces of transfected animals
by 2 to 3 weeks following transfection (Fig. 2). By semiquan-
titative slot blot hybridization (12), both animals transfected
with the D96-137/8Y RNA were estimated to have shed virus
equivalent to approximately 107.0 to 107.8 50% tissue culture
infective doses of cell culture-adapted virus per g of stool on
days of maximal virus shedding. The timing of maximal virus
excretion (2 to 3 weeks posttransfection) and the duration of
shedding (approximately 2 to 3 weeks) were similar to those
observed during previous transfections of marmosets with
HM175/8Y RNA (10).
Weekly serum samples were tested for anti-HAV antibodies
by a competitive inhibition immunoassay (HAVAB-EIA; Ab-
bott Laboratories). Animal 787 seroconverted 3 weeks post-
transfection, and animal 788 seroconverted 4 weeks posttrans-
fection (Fig. 2). Although biological variability in these
outbred, wild-caught marmosets may have some effect on the
course of infection, animals that develop high serum liver en-
zyme elevations generally develop antibodies to HAV by 6
weeks posttransfection (6). In contrast, in infected animals
with normal or only slightly elevated serum liver enzyme ac-
tivities, seroconversion occurs later, most often between weeks
7 to 9 but occasionally as late as 22 weeks with some attenuated
virus variants. Thus, the appearance of anti-HAV antibodies in
marmosets 787 and 788 was consistent with the pattern ob-
served in prior experiments involving intrahepatic transfection
with virulent HAV RNA. In both animals, seroconversion co-
incided with peak serum liver enzyme activities, as is typical in
acute hepatitis A (16).
Because the D96-137/8Y virus did not appear to be impaired
with respect to either replication or the ability to induce acute
hepatitis in marmosets, it was of interest to determine whether
the D96-137 deletion was retained by virus shed in feces. Se-
quencing of viral RNA from lysates of D96-137/8Y RNA-trans-
fected FRhK-4 cells and from marmoset fecal samples was
carried out by using an antigen capture PCR method followed
by cycle sequencing using DTaq DNA Polymerase (United
States Biochemical Corp.) (15, 19). As shown in Fig. 3, the
original D96-137 deletion was present in the virus rescued
following RNA transfection of FRhK-4 cells as well as in the
virus shed in stool by marmoset 788. Similar sequencing results
were obtained with virus from the stool of marmoset 787 (data
not shown). Thus, the D96-137/8Y virus is not impaired in
replication following intrahepatic nucleic acid transfection of
susceptible marmosets.
pY1 domains, containing at least three repeats of the
(U)UUCC(C) sequence motif, are present in all human hepa-
tovirus strains which have been sequenced to date (19). Al-
though the pY1 domain occupies a position within the 59NTR
which is immediately upstream of the IRES (2, 20, 22), anal-
ogous to that occupied by poly(C) tracts in cardioviruses (5),
this unique sequence element is not found in any other picor-
navirus. One would expect that the pY1 domain would be
FIG. 2. HAV infection following intrahepatic transfection of two marmosets
with D96-137/8Y RNA. The bar graph at the top of each panel represents
histologic scores (0 to 31) of percutaneous needle biopsy samples of liver (see
text). Solid squares represent fecal samples strongly positive for HAV RNA by
slot blot hybridization, while open squares represent fecal samples which were
negative for viral RNA. Serum alanine aminotransferase (ALT; F) and isocitrate
dehydrogenase (ICDH; E) activities are represented with the appropriate scales
shown at the left, while g-glutamyl transpeptidase (GTP; p) activity is shown with
the scale at the right. The presence of serum anti-HAV antibody detectable by
a competitive inhibition immunoassay is indicated by the striped horizontal box.
FIG. 3. RNA sequence of virus recovered following transfection of FRhK-4
cells (A) and from the stool of marmoset 788 (B), which was inoculated intra-
hepatically with D96-137/8Y RNA. The arrowhead at the left of each sequence
indicates the position of the D96-137 deletion.
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rapidly lost from all hepatovirus strains if it were not important
for some phase of the viral life cycle. However, previous studies
have shown that the pY1 domain is not required for efficient
replication of cell culture-adapted HAV in cultured monkey
kidney cells (19). These findings were confirmed here in trans-
fections of cultured cells with viral RNA lacking the pY1 do-
main as well as all but one of the mutations shown previously
to contribute to growth in cultured cells (4, 7–9, 11). More
importantly, the experiments described here clearly demon-
strate that the pY1 domain is not required for efficient repli-
cation of HAV in primate hepatocytes in situ or for production
of acute hepatocellular injury.
These results suggest that the pY1 domain of HAV may
have a function which is distinct from that of the large pyrim-
idine-rich tracts which are located upstream of the IRESs in
the 59NTRs of the aphthoviruses and cardioviruses (5, 18). The
latter are substantially longer, nearly pure poly(C) tracts, while
the pY1 domain of HAV contains numerous uridylic acids, as
described above (Table 2). Genetically engineered short
poly(C) tract variants of foot-and-mouth virus (FMDV) were
unstable during passage in cell culture and rapidly reverted to
variants with longer poly(C) tracts (C75 to C140) (18). In addi-
tion, a short poly(C) (C2) FMDV variant which was genetically
stable but replicated poorly in cell culture was shown to be
virulent in mice (18). These data suggest that the poly(C) tract
of FMDV is required for efficient replication in cultured cells
but not for virulence in mice. On the other hand, the poly(C)
tract of mengovirus is not necessary for efficient replication in
cultured cells but is required for virulence in mice following
intracranial or intraperitoneal inoculation (5). Recently, Hahn
and Palmenberg (14) reported that short poly(C) tract variants
of encephalomyocarditis virus replicated nearly as well as pa-
rental virus in cultured cells but were only minimally attenu-
ated in mice. In contrast to FMDV and mengovirus (and re-
sembling the situation with encephalomyocarditis virus), the
pyrimidine-rich tract of HAV is required neither for replica-
tion in either cultured cells or hepatocytes in situ nor for
virulence in intrahepatically transfected primates (Table 2).
The role of this unique hepatovirus sequence element re-
mains unclear. The single-stranded RNA segment immediately
downstream of the pY1 domain appears to play a critical role
in replication of the viral RNA (20), but thus far it has not been
possible to assign a function to the oligopyrimidine tract. It is
possible that the pY1 domain is required for infection of cells
within the gastrointestinal tract or in circulating leukocytes,
both of which could serve as sites of primary viral replication
prior to infection of hepatocytes during natural HAV infec-
tions. However, it is important to note that the mechanisms by
which the virus reaches the liver and the existence of any
putative sites of primary virus replication are as yet undefined
(16). Because the marmoset infections described here were
carried out by direct intrahepatic nucleic acid transfection,
impairment in earlier steps of the infectious cycle in the pri-
mate host would not have been observed. Further studies in
which D96-137/8Y virus rescued by RNA transfection of cul-
tured cells is inoculated into susceptible primate hosts per-
orally will be required to determine whether the pY1 domain
in some way enables HAV to establish infection within the
liver.
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